A leap towards enforcing medicines prescribing by generic names in low- and middle-income countries (LMICs): pitfalls, limitations, and recommendations for local drug regulatory agencies

The Drug Regulatory Authority of Pakistan (DRAP) in response to the public outcry on increasing medicines prices in the country issued notifications to direct healthcare professionals to prescribe medicines with their generic names. Like DRAP, many regulators in the low- and middle-income countries...

Descripción completa

Detalles Bibliográficos
Autores principales: Merchant, Hamid A., Babar, Zaheer-Ud-Din, Hussain, Izhar M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773520/
https://www.ncbi.nlm.nih.gov/pubmed/36550588
http://dx.doi.org/10.1186/s40545-022-00501-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773520/
https://www.ncbi.nlm.nih.gov/pubmed/36550588
http://dx.doi.org/10.1186/s40545-022-00501-4

Ejemplares similares